ZICX:OTO-Zicix Corporation (USD)

COMMON STOCK | Software - Application | OTC Pink

Last Closing

USD 0.0005

Change

0.00 (-28.57)%

Market Cap

USD 0.02B

Volume

926.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Zicix Corp provides medical diagnostic services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Software - Application

Symbol Name Price(Change) Market Cap
SAPGF SAP SE

+0.47 (+0.16%)

USD 325.94B
CNSWF Constellation Software Inc

+45.54 (+1.33%)

USD 70.14B
WTCHF WiseTech Global Limited

N/A

USD 26.82B
DIDIY Didi Global Inc ADR

+0.04 (+0.84%)

USD 24.07B
XROLF Xero Limited

+3.00 (+2.68%)

USD 17.78B
SGGEF The Sage Group plc

+0.07 (+0.41%)

USD 17.24B
NEMKY Nemetschek SE

N/A

USD 14.59B
LMGIF Lumine Group Inc.

-0.01 (-0.04%)

USD 7.34B
TMSNY Temenos Group AG ADR

-0.39 (-0.46%)

USD 6.35B
FNOXF Fortnox AB (publ)

N/A

USD 4.30B

ETFs Containing ZICX

ZMU:CA BMO Mid-Term US IG Corpor.. 99.81 % 0.27 %

N/A

CAD 3.07B
ETP:CA First Trust Global Risk M.. 0.00 % 0.98 %

+0.03 (+0.00%)

CAD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Software - Application) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.00% 75% C 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.00% 75% C 80% B-
Trailing 12 Months  
Capital Gain -28.57% 44% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -28.57% 43% F 30% F
Trailing 5 Years  
Capital Gain -92.31% 38% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -92.31% 38% F 18% F
Average Annual (5 Year Horizon)  
Capital Gain -35.67% 11% F 5% F
Dividend Return -35.67% 11% F 5% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 45.20% 73% C 55% F
Risk Adjusted Return -78.92% 10% F 7% C-
Market Capitalization 0.02B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative earnings

The company had negative total earnings in the most recent four quarters.